Shelton’s NanoViricides has licensed, from West Haven’s TheraCour Pharma, a set of drugs that show promise against COVID-19. The licensed drugs include antiviral treatments for the SARS-CoV-2 virus and its variants.
In March, NanoViricides announced that two of its COVID-19 drug candidates had been “highly effective” against the virus in pre-clinical laboratory studies.